Can dietary sources provide enough lactoferrin to reach 600mg?

Standard cow's milk contains roughly 10–30mg of lactoferrin per 100mL. Reaching the 600mg dose tested in this trial through food alone would require drinking more than 2 liters of milk daily, which is not practical. Colostrum products contain significantly higher concentrations, but regular consumption at therapeutic volumes is difficult. Supplements remain the realistic route for reaching clinically relevant doses.

Does this research apply to adults under 50?

This trial specifically enrolled healthy adults aged 50 and over. Lactoferrin's antimicrobial, antiviral, and iron absorption benefits have been documented in younger adults in separate studies, but the immune cell changes observed here were in a 50+ cohort. The fact that effects are more pronounced when immune aging is underway is part of what makes the findings clinically relevant for this population.

Are there any interactions to be aware of with lactoferrin?

Lactoferrin is an iron-binding protein, so timing alongside iron supplements may affect absorption dynamics for both. People with a dairy protein allergy should check product sourcing, as most commercial lactoferrin is bovine-derived. If you are on immunosuppressive medication, a conversation with your physician before adding lactoferrin is the right step.

Lactoferrin 600mg Reawakens Immune Cells After Age 50

Immune function does not decline uniformly with age. The specific mechanism involves real changes in immune cell composition: T cells that coordinate targeted responses diminish, and a persistent low-level inflammatory state builds in the background. A randomized double-blind trial published in the Proceedings of the Nutrition Society found that 600mg of lactoferrin taken daily for four weeks by healthy adults over 50 increased T cell populations and significantly reduced inflammatory markers IL-6 and CRP.

What lactoferrin actually is

Lactoferrin is a multifunctional protein present in breast milk and in secretions throughout the body, including tears, saliva, bronchial mucus, and the gut lining. The name refers to its dairy association, but the protein’s role extends far beyond infant nutrition.

Its structure allows it to bind two iron ions simultaneously. This iron-sequestration capacity is central to its antimicrobial and antiviral function: bacteria and viruses require iron to replicate, and lactoferrin competes for that iron before pathogens can use it. Separately, lactoferrin interacts directly with immune cell receptors, modulating the signaling that governs both innate and adaptive immune responses.

Concentrations vary substantially across sources. Human colostrum contains approximately 490mg per 100mL; mature human milk drops to around 160mg. Bovine milk used in supplements and food products runs 10–30mg per 100mL, considerably lower than human milk. The observation that the body’s own secreted lactoferrin may decline with age helped motivate this particular trial’s focus on supplementation in older adults.

Immune aging and inflammaging

After age 50, the immune system changes along two parallel tracks. The adaptive immune system, which produces specific targeted responses to pathogens via T cells and B cells, becomes less responsive. New threats are met more slowly and with less precision. At the same time, a chronic background inflammation develops. Inflammatory markers including IL-6, CRP, and TNF-alpha become structurally elevated, not in response to any specific infection, but as a persistent baseline condition. Researchers refer to this combination as inflammaging.

The result is paradoxical: the immune system responds poorly to acute threats while maintaining an elevated chronic inflammatory burden. This background inflammation connects to muscle loss, cardiovascular risk, and insulin resistance, making immune aging a meaningful target for healthy aging research.

The numbers from the 4-week trial

The study enrolled 103 healthy adults aged 50 and over, divided into three parallel arms: high-dose lactoferrin (600mg/day), low-dose lactoferrin (200mg/day), and placebo. Ninety-six participants completed follow-up.

High-dose group findings:

Significant increase in total T cells and CD4+ T helper cells versus placebo
Rhinovirus-induced IL-6 reduced, p = 0.001 versus placebo
Plasma IL-6 and CRP significantly lower than the low-dose group
Increased antiviral cytokine production in response to respiratory virus stimulation (rhinovirus and influenza)

The 200mg group showed a different pattern. Circulating neutrophils, natural killer cells, and certain T cell subsets decreased. This represents modulation of innate and cytotoxic immune pathways rather than the adaptive immune expansion seen with the higher dose. Two doses, two distinct mechanisms.

No adverse effects were reported in any group.

What the dose difference means

The distinction between the 600mg and 200mg outcomes is not simply a matter of more versus less of the same effect. The two doses appear to engage different immune pathways. High-dose lactoferrin supported adaptive immunity by expanding T cell populations and reducing systemic inflammation. Low-dose lactoferrin modulated innate immune cell frequency, reducing pro-inflammatory and cytotoxic cell circulation.

Neither pattern is straightforwardly “better.” Depending on the individual’s starting immune profile and health context, one pathway may be more relevant than the other. What the data establishes clearly is that the dose distinction is not trivial, and the 600mg threshold may be necessary to observe the T cell and systemic inflammatory effects.

Most commercial lactoferrin supplements currently sit in the 200–400mg range. The 600mg dose in this trial is at the higher end of what is routinely available, and this trial provides the first placebo-controlled comparison of what that dose produces immunologically in older adults.

Why food sources fall short

A 200mL glass of milk contains approximately 20–60mg of lactoferrin. Reaching 600mg from dairy alone would require consuming 2 to 6 liters daily. Colostrum products offer higher concentrations, but typical serving volumes do not close the gap at practical levels.

There is a second obstacle. Lactoferrin is a protein, and like most proteins, it faces partial degradation in the acidic stomach environment before reaching the small intestine where absorption occurs. Enteric-coated lactoferrin, designed to survive gastric passage intact, has shown approximately ten times higher bioavailability than uncoated forms. For supplementation at therapeutic doses, the processing method matters as much as the dose printed on the label.

What to look for in a supplement

Commercial lactoferrin supplements draw from two main sources. Bovine lactoferrin extracted from cow’s milk or colostrum is the dominant category. Recombinant human lactoferrin, produced through transgenic animals or plant-based systems (most commonly rice), more closely matches native human lactoferrin in structure and shows similar biological activity in research settings. It may also carry lower allergenicity for people sensitive to bovine proteins.

Key factors to evaluate:

Enteric coating (affects bioavailability at higher doses)
Source designation (bovine lactoferrin vs recombinant human lactoferrin)
Iron saturation state (apo-lactoferrin, the iron-free form, retains higher antimicrobial activity)

Applications outside of immune aging

Lactoferrin research extends well beyond immunity. In iron-deficient adults and infants, lactoferrin supplementation has improved serum iron, ferritin, and transferrin saturation. Studies suggest that even small amounts, around 25mg per liter in formula, were sufficient to measurably improve iron metabolism in infants, despite the protein’s iron-binding behavior creating an initial counterintuitive picture.

In oral health, lactoferrin’s antibacterial properties have been studied for periodontal pathogen suppression and mucosal recovery. Clinical trials are ongoing for its use in reducing oral mucositis during cancer treatment.

Bone health is a separate area of investigation. Animal model studies have reported improvements in bone mass, bone strength, and bone mineral density, with some clinical signals appearing in human research as well.

This trial’s value is in its specificity: an aging immune population, a controlled dose comparison, and a focus on the pathways most relevant to the inflammaging pattern that characterizes immune decline after 50.

Before adding a lactoferrin supplement, it is worth checking whether your current multivitamin or combination supplement already includes it. Many formulas aimed at immune support do. Starting from what you already take gives you a clearer view of what, if anything, needs to be added.

Source: Cambridge - Proceedings of the Nutrition Society